Get the Stockscreener App
1.83
1.67%
0.03
After Hours:
1.82
-0.01
-0.55%
Matinas Biopharma Holdings Inc stock is traded at $1.83, with a volume of 48,214.
It is up +1.67% in the last 24 hours and up +23.65% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$1.80
Open:
$1.82
24h Volume:
48,214
Relative Volume:
0.09
Market Cap:
$9.31M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.382
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
+6.40%
1M Performance:
+23.65%
6M Performance:
+242.06%
1Y Performance:
-50.14%
1-Day Range:
$1.76
$1.88
1-Week Range:
$1.59
$1.88
52-Week Range:
$0.4748
$4.25
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.83 | 9.00M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-26-20 | Resumed | Piper Sandler | Overweight |
| Jan-27-20 | Initiated | Piper Sandler | Overweight |
| Jan-24-20 | Initiated | SunTrust | Buy |
| Jan-23-20 | Initiated | SunTrust | Buy |
| Jan-09-20 | Initiated | Aegis Capital | Buy |
| Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
Why Matinas BioPharma Holdings Inc. is moving todayJuly 2025 Reactions & High Conviction Investment Ideas - Newser
What does recent volatility data suggest for Matinas BioPharma Holdings Inc.Earnings Overview Summary & Weekly High Return Opportunities - Newser
Price action breakdown for Matinas BioPharma Holdings Inc.2025 Key Lessons & AI Based Buy/Sell Signal Reports - Newser
Using data models to predict Matinas BioPharma Holdings Inc. stock movement2025 Market Outlook & Safe Capital Growth Tips - Newser
matinas biopharma holdings inc. stock momentum explainedJuly 2025 Review & AI Enhanced Trade Execution Alerts - Newser
How to monitor Matinas BioPharma Holdings Inc. with trend dashboards2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - Newser
What the charts say about Matinas BioPharma Holdings Inc. todayTreasury Yields & Fast Gaining Stock Reports - Newser
Advanced analytics toolkit walkthrough for Matinas BioPharma Holdings Inc.Market Performance Report & Reliable Breakout Forecasts - Newser
Trend analysis for Matinas BioPharma Holdings Inc. this weekJuly 2025 Selloffs & Safe Capital Growth Tips - Newser
What machine learning models say about Matinas BioPharma Holdings Inc.Fed Meeting & Daily Chart Pattern Signal Reports - Newser
Risk vs reward if holding onto Matinas BioPharma Holdings Inc.2025 Dividend Review & Daily Chart Pattern Signal Reports - Newser
Matinas BioPharma Holdings Inc. stock trend forecastJuly 2025 Market Mood & Safe Entry Trade Reports - Newser
Can machine learning forecast Matinas BioPharma Holdings Inc. recoveryJuly 2025 Sector Moves & Fast Gain Stock Tips - Newser
How to interpret RSI for Matinas BioPharma Holdings Inc. stockJuly 2025 Volume & Daily Entry Point Alerts - Newser
Is Matinas BioPharma Holdings Inc. stock ready for a breakoutWeekly Profit Summary & Fast Moving Stock Watchlists - Newser
Matinas BioPharma Holdings Inc. stock momentum explained2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Using AI based signals to follow Matinas BioPharma Holdings Inc.2025 Sector Review & Short-Term High Return Strategies - Newser
Applying Wyckoff theory to Matinas BioPharma Holdings Inc. stock2025 Market WrapUp & Weekly High Return Stock Forecasts - Newser
What’s the recovery path for long term holders of Matinas BioPharma Holdings Inc.Weekly Profit Recap & Consistent Growth Equity Picks - Newser
Heatmap analysis for Matinas BioPharma Holdings Inc. and competitors2025 Momentum Check & Reliable Intraday Trade Plans - Newser
Exit strategy if you’re trapped in Matinas BioPharma Holdings Inc.July 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Real time alert setup for Matinas BioPharma Holdings Inc. performance2025 Technical Patterns & Free Expert Approved Momentum Trade Ideas - Newser
Reversal indicators forming on Matinas BioPharma Holdings Inc. stockGap Down & Free Long-Term Investment Growth Plans - Newser
Custom watchlist performance reports with Matinas BioPharma Holdings Inc.2025 Market WrapUp & Safe Entry Point Identification - Newser
What indicators show strength in Matinas BioPharma Holdings Inc.July 2025 PreEarnings & Stepwise Entry and Exit Trade Signals - Newser
Real time social sentiment graph for Matinas BioPharma Holdings Inc.July 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Combining price and volume data for Matinas BioPharma Holdings Inc.Analyst Upgrade & Reliable Intraday Trade Alerts - Newser
Real time breakdown of Matinas BioPharma Holdings Inc. stock performance2025 Retail Activity & Accurate Buy Signal Notifications - Newser
Does Matinas BioPharma Holdings Inc. show high probability of reboundJuly 2025 News Drivers & Risk Adjusted Swing Trade Ideas - Newser
Will Matinas BioPharma Holdings Inc. see short term momentumWeekly Trade Review & Fast Moving Stock Trade Plans - Newser
trend analysis for matinas biopharma holdings inc. this weekWeekly Profit Report & Verified Technical Trade Signals - Newser
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):